{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:10:17Z","timestamp":1778764217914,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA041367"],"award-info":[{"award-number":["R01 DA041367"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["NCT03291847"],"award-info":[{"award-number":["NCT03291847"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotoxicology and Teratology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ntt.2024.107368","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T11:59:22Z","timestamp":1718798362000},"page":"107368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gestational buprenorphine-naloxone exposure and fetal neurobehavior"],"prefix":"10.1016","volume":"104","author":[{"given":"Lauren M.","family":"Jansson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystle","family":"McConnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha L.","family":"Velez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"Milio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannie","family":"Leoutsakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet A.","family":"DiPietro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ntt.2024.107368_bb0005","first-page":"495","article-title":"Effects of naloxone on the breathing, electrocortical, heart rate, glucose and cortisol responses to hypoxia in the sheep fetus","volume":"6","author":"Adamson","year":"1984","journal-title":"J. Dev. Physiol."},{"issue":"2","key":"10.1016\/j.ntt.2024.107368_bb0010","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0002-9378(87)90313-9","article-title":"Effect of naloxone on fetal behavior near term","volume":"156","author":"Arduini","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ntt.2024.107368_bb0015","author":"Centers for Disease Control and Prevention"},{"issue":"4","key":"10.1016\/j.ntt.2024.107368_bib170","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1152\/jappl.2001.90.4.1577","article-title":"Effects of morphine and naloxone on fetal heart rate and movement in the pig","volume":"90","author":"Cohen","year":"2001","journal-title":"Journal of Applied Physiology (Bethesda, MD: 1985)"},{"issue":"2","key":"10.1016\/j.ntt.2024.107368_bb0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/FTD.0b013e3181d0bd68","article-title":"Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes","volume":"32","author":"Concheiro","year":"2010","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.ntt.2024.107368_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuroscience.2015.07.068","article-title":"The gestational foundation of sex differences in development and vulnerability","volume":"342","author":"DiPietro","year":"2017","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.ntt.2024.107368_bb0035","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1037\/0012-1649.40.3.445","article-title":"Fetal neurobehavioral development: a tale of two cities","volume":"40","author":"DiPietro","year":"2004","journal-title":"Dev. Psychol."},{"issue":"4","key":"10.1016\/j.ntt.2024.107368_bib166","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/0002-9378(83)90828-1","article-title":"The autonomic nervous system and fetal heart rate variability","volume":"146","author":"Dalton","year":"1983","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.ntt.2024.107368_bb0040","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/j.1467-8624.2007.01099.x","article-title":"Fetal heart rate and variability: stability and prediction to developmental outcomes in early childhood","volume":"78","author":"DiPietro","year":"2007","journal-title":"Child Dev."},{"issue":"1","key":"10.1016\/j.ntt.2024.107368_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1467-8624.2009.01384.x","article-title":"Prenatal antecedents of newborn neurological maturation","volume":"81","author":"DiPietro","year":"2010","journal-title":"Child Dev."},{"key":"10.1016\/j.ntt.2024.107368_bb0050","first-page":"1","article-title":"Studies in fetal behavior: revisited, renewed, and reimagined","volume":"80","author":"DiPietro","year":"2015","journal-title":"Monogr. Soc. Res. Child Dev."},{"issue":"4","key":"10.1016\/j.ntt.2024.107368_bb0055","first-page":"e194","article-title":"Buprenorphine-naloxone use in pregnancy for treatment of opioid dependence","volume":"62","author":"Dooley","year":"2016","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.ntt.2024.107368_bb0060","series-title":"Buprenorphine for Opioid Use Disorders during Pregnancy: A Review of Comparative Clinical Effectiveness, Safety, Cost-Effectiveness, and Guidelines [Internet]","author":"Edge","year":"2019"},{"key":"10.1016\/j.ntt.2024.107368_bib169","series-title":"Fetal behaviour: A neurodevelopmental approach. Clinics in Developmental Medicine No 189","author":"Einspieler","year":"2012"},{"issue":"7","key":"10.1016\/j.ntt.2024.107368_bb0065","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2165\/00003088-200544070-00001","article-title":"Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence","volume":"44","author":"Elkader","year":"2005","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.ntt.2024.107368_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2020.24991","article-title":"Neonatal abstinence syndrome and maternal opioid-related diagnoses in the US, 2010-2017","volume":"325","author":"Hirai","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ntt.2024.107368_bb0075","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2009.0006","article-title":"The opioid-exposed newborn: assessment and pharmacologic management","volume":"5","author":"Jansson","year":"2009","journal-title":"J. Opioid Manag."},{"issue":"2","key":"10.1016\/j.ntt.2024.107368_bb0080","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ntt.2010.09.003","article-title":"Fetal neurobehavioral effects of exposure to methadone or buprenorphine","volume":"33","author":"Jansson","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ntt.2024.107368_bb0085","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugalcdep.2017.08.001","article-title":"Maternal buprenorphine treatment and infant outcome","volume":"180","author":"Jansson","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.ntt.2024.107368_bb0090","doi-asserted-by":"crossref","first-page":"529.e1","DOI":"10.1016\/j.ajog.2017.01.040","article-title":"Maternal buprenorphine treatment and fetal neurobehavioral development","volume":"216","author":"Jansson","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.ntt.2024.107368_bb0095","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ogc.2018.01.008","article-title":"Opioid use disorders and pregnancy","volume":"45","author":"Johnson","year":"2018","journal-title":"Obstet. Gynecol. Clin. N. Am."},{"key":"10.1016\/j.ntt.2024.107368_bb0100","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome after methadone or buprenorphine exposure","volume":"363","author":"Jones","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ntt.2024.107368_bb0105","series-title":"StatPearls [Internet]","author":"Jordan","year":"2023"},{"issue":"3","key":"10.1016\/j.ntt.2024.107368_bb0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/aogs.14497","article-title":"Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder","volume":"102","author":"Kanervo","year":"2023","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"2","key":"10.1016\/j.ntt.2024.107368_bb0115","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0014-4886(81)90277-6","article-title":"Effects of morphine and naloxone on spontaneous activity of fetal rats","volume":"73","author":"Kirby","year":"1981","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.ntt.2024.107368_bb0120","doi-asserted-by":"crossref","first-page":"100179","DOI":"10.1016\/j.ajogmf.2020.100179","article-title":"Buprenorphine-naloxone use in pregnancy: a systematic review and metaanalysis","volume":"2","author":"Link","year":"2020","journal-title":"Am J Obstet Gynecol MFM."},{"issue":"1","key":"10.1016\/j.ntt.2024.107368_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1124\/jpet.300.1.26","article-title":"Transplacental transfer and metabolism of buprenorphine","volume":"300","author":"Nanovskaya","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.ntt.2024.107368_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/pathophysiology30010004","article-title":"Safety and efficacy of buprenorphine-naloxone in pregnancy: a systematic review of the literature","volume":"30","author":"Ordean","year":"2023","journal-title":"Pathophysiology."},{"issue":"5","key":"10.1016\/j.ntt.2024.107368_bb0135","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","article-title":"Buprenorphine-naloxone: a review of its use in the treatment of opioid dependence","volume":"69","author":"Orman","year":"2009","journal-title":"Drugs."},{"issue":"Suppl 1(0 1)","key":"10.1016\/j.ntt.2024.107368_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1360-0443.2012.04037.x","article-title":"Fetal assessment before and after dosing with buprenorphine or methadone","volume":"107","author":"Salisbury","year":"2012","journal-title":"Addiction."},{"issue":"4","key":"10.1016\/j.ntt.2024.107368_bb0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9378(85)90266-2","article-title":"Precipitated opiate abstinence in utero","volume":"151","author":"Umans","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"5","key":"10.1016\/j.ntt.2024.107368_bb0150","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.ntt.2024.107368_bib167","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.clp.2012.09.001","article-title":"Identification, assessment and management of fetal compromise","volume":"39","author":"Walton","year":"2012","journal-title":"Clin. Perinatol."},{"issue":"5","key":"10.1016\/j.ntt.2024.107368_bib168","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/dev.20232","article-title":"Prenatal predictors of infant temperament","volume":"49","author":"Werner","year":"2007","journal-title":"Dev. Psychobiol."},{"issue":"4","key":"10.1016\/j.ntt.2024.107368_bb0155","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1055\/s-0036-1593993","article-title":"Naloxone and metabolites quantification in cord blood of prenatally exposed newborns and correlations with maternal concentrations","volume":"6","author":"Wiegand","year":"2016","journal-title":"AJP Rep."},{"issue":"9","key":"10.1016\/j.ntt.2024.107368_bb0160","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.clinthera.2019.06.003","article-title":"The impact of the opioid epidemic on children and adolescents","volume":"41","author":"Winstanley","year":"2019","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ntt.2024.107368_bb0165","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/bcp.13642","article-title":"Gestational changes in buprenorphine exposure: a physiologically-based pharmacokinetic analysis","volume":"84","author":"Zhang","year":"2018","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Neurotoxicology and Teratology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036224000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892036224000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:34:00Z","timestamp":1778762040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892036224000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":37,"alternative-id":["S0892036224000503"],"URL":"https:\/\/doi.org\/10.1016\/j.ntt.2024.107368","relation":{},"ISSN":["0892-0362"],"issn-type":[{"value":"0892-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gestational buprenorphine-naloxone exposure and fetal neurobehavior","name":"articletitle","label":"Article Title"},{"value":"Neurotoxicology and Teratology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ntt.2024.107368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107368"}}